Bank Plus Trust Department Teva Pharmaceutical Industries LTD Transaction History
Bank Plus Trust Department
- $300 Billion
- Q1 2025
A detailed history of Bank Plus Trust Department transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Bank Plus Trust Department holds 754 shares of TEVA stock, worth $12,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
754Holding current value
$12,358% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
665Shares Held
618MCall Options Held
24.8MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$705 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$639 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$601 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$465 Million3.94% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L327.5MShares$450 Million6.56% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...